KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES

KAIMRC and Flagship Pioneering Form $70M Partnership for Genetic Disease Clinical Trials in Saudi Arabia

- King Abdullah International Medical Research Center and Flagship Pioneering announced a strategic partnership to conduct early-phase clinical trials of novel genetic disease therapies in Saudi Arabia. - The collaboration will initially focus on three Phase 1 programs and one Phase 2 program from Flagship-founded companies targeting genetic diseases with high unmet medical need. - Saudi investors will commit $70 million to participating U.S.-based companies as part of the partnership framework. - The agreement aims to establish Saudi Arabia as a leader in innovative clinical trials while advancing American biotechnology innovation globally.